Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipecac homeopathic remedy for clinical manifestations of COVID-19
IRCT20140907019073N4Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Ipecac in coronavirus disease 2019 (COVID-19), sponsored by Iran University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
Ipecac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20140907019073N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140907019073N4.